H. Solvason

发表

Resting-State Functional Connectivity in Major Depression: Abnormally Increased Contributions from Subgenual Cingulate Cortex and Thalamus

G. Glover, M. Greicius, V. Menon, 2007, Biological Psychiatry.

Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial

William W. McDonald, J. O'reardon, H. Sackeim, 2007, Biological Psychiatry.

Stanford accelerated intelligent neuromodulation therapy for treatment-resistant depression (SAINT-TRD)

A. Schatzberg, H. Solvason, J. Keller, 2019, Brain Stimulation.

Psychological versus biological clinical interpretation: a patient with prion disease.

Benjamin H. Flores, H. Solvason, B. Harris, 2002, The American journal of psychiatry.

Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depression.

A. Reiss, A. Schatzberg, H. Solvason, 2008, The American journal of psychiatry.

Conditioning: A New Approach to Immunotherapy1

H. Solvason, S. Soong, N. Hiramoto, 2006 .

A 25-year-old woman with hallucinations, hypersexuality, nightmares, and a rash.

H. Solvason, D. Spiegel, E. Biggart, 1996, The American journal of psychiatry.

Case report: limbic system activation by intravenous lidocaine in a patient with a complex regional pain syndrome and major depression.

H. Solvason, M. Leong, A. B. S T R, 2000, Pain medicine.

Naltrexone blocks the expression of the conditioned elevation of natural killer cell activity in BALB c mice

H. Solvason, R. Hiramoto, V. Ghanta, 1989, Brain, Behavior, and Immunity.

Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression.

A. Schatzberg, H. Solvason, C. Debattista, 2000, Journal of clinical psychopharmacology.

Agranulocytosis associated with lamotrigine.

H. Solvason, 2000, The American journal of psychiatry.

Conditioning: a new approach to immunotherapy.

H. Solvason, S. Soong, R. Hiramoto, 1990, Cancer research.

Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression

A. Schatzberg, Benjamin H. Flores, H. Solvason, 2006, Neuropsychopharmacology.

Predictors of response in anxiety disorders.

W. Roth, H. Solvason, H. Ernst, 2003, The Psychiatric clinics of North America.

The identity of the unconditioned stimulus to the central nervous system is interferon-β

H. Solvason, R. Hiramoto, V. Ghanta, 1993, Journal of Neuroimmunology.

A Prospective Trial of Bupropion SR Augmentation of Partial and Non-Responders to Serotonergic Antidepressants

A. Schatzberg, H. Solvason, C. Debattista, 2003, Journal of clinical psychopharmacology.

Psychoneuroendocrine immunology: perception of stress can alter body temperature and natural killer cell activity.

H. Solvason, D. Gauthier, J. Lorden, 1999, The International journal of neuroscience.

Neural and environmental influences on neoplasia and conditioning of NK activity.

H. Solvason, N. H. Spector, R. Hiramoto, 1985, Journal of immunology.

Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice

H. Solvason, D. Dunner, P. Janicak, 2013, CNS Spectrums.

TRANSCRANIAL MAGNETIC STIMULATION (TMS) FOR MAJOR DEPRESSION: A MULTISITE, NATURALISTIC, OBSERVATIONAL STUDY OF ACUTE TREATMENT OUTCOMES IN CLINICAL PRACTICE

H. Solvason, D. Dunner, P. Janicak, 2012, Depression and anxiety.

Improvement in Quality of Life With Left Prefrontal Transcranial Magnetic Stimulation in Patients With Pharmacoresistant Major Depression: Acute and Six Month Outcomes

H. Solvason, P. Fitzgerald, M. Demitrack, 2014, Brain Stimulation.

A Simple, Single, Trial-Learning Paradigm for Conditioned Increase in Natural Killer Cell Activity

H. Solvason, S. Soong, R. Hiramoto, 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

A behavioral augmentation of natural immunity: odor specificity supports a Pavlovian conditioning model.

S J Soong, H. Solvason, S. Soong, 1991, The International journal of neuroscience.

Conditioned augmentation of natural killer cell activity. Independence from nociceptive effects and dependence on interferon-beta.

H. Solvason, R. Hiramoto, V. Ghanta, 1988, Journal of immunology.

Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study

Sarah H. Lisanby, Andrew Krystal, William W. McDonald, 2010, Brain Stimulation.

Cortisol Circadian Rhythm Alterations in Psychotic Major Depression

A. Schatzberg, Benjamin H. Flores, H. Solvason, 2006, Biological Psychiatry.

A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period.

H. Sackeim, H. Solvason, D. Dunner, 2014, The Journal of clinical psychiatry.

fficacy and Safety of Transcranial Magnetic timulation in the Acute Treatment of Major epression : A Multisite Randomized Controlled Trial

H. Sackeim, H. Solvason, W. McDonald, 2007 .

Coadministration of Modafinil and a Selective Serotonin Reuptake Inhibitor From the Initiation of Treatment of Major Depressive Disorder With Fatigue and Sleepiness: A Double-Blind, Placebo-Controlled Study

R. Gallop, H. Solvason, B. Dunlop, 2007, Journal of clinical psychopharmacology.

Antidepressant Dosing for the Acute Treatment of Unipolar Depression

H. Solvason, C. Debattista, 2009 .

A Prospective Trial of Modafinil as an Adjunctive Treatment of Major Depression

H. Solvason, C. Debattista, A. Lembke, 2004, Journal of clinical psychopharmacology.

Regulation of Natural Immunity (NK Activity) by Conditioning a

H. Solvason, R. Hiramoto, N. Hiramoto, 1987, Annals of the New York Academy of Sciences.

Reply Regarding “Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial”

J. O'reardon, H. Sackeim, H. Solvason, 2010, Biological Psychiatry.